TCT 2021

Transplantation & Cellular Therapy (TCT) 2021 Meeting

08–12 February 2021 | Virtual Meeting

The Transplantation & Cellular Therapy (TCT) 2021 Meeting was held virtually this year due to the ongoing COVID-19 pandemic and highlighted recent advances in the field of transplantation and cellular therapies.

View all videos

Anti-CD117 mAb synergizes with 5-azacytidine to augment engraftment of HSCs in mice

Andriyana K. Bankova • 26 Feb 2021

Clinical outcomes of cryopreserved graft recipients following allo-HCT

Andriyana K. Bankova • 26 Feb 2021

Highlights from TCT 2021

Pavan Reddy • 24 Feb 2021

Future directions of immune cell therapy in lymphoma

Yago Nieto • 15 Feb 2021

Anti-CD117 mAb synergizes with 5-azacytidine to augment engraftment of HSCs in mice

Andriyana K. Bankova • 26 Feb 2021

Clinical outcomes of cryopreserved graft recipients following allo-HCT

Andriyana K. Bankova • 26 Feb 2021

Highlights from TCT 2021

Pavan Reddy • 24 Feb 2021

Updates on transplant for patients with myeloma

Sergio Giralt • 22 Feb 2021

Highlights from TCT 2021

Pavan Reddy • 24 Feb 2021

Future directions of immune cell therapy in lymphoma

Yago Nieto • 15 Feb 2021

Long-term follow-up of a “fast-DC” immunotherapy as a post-remission strategy for AML

Yngvar Floisand • 11 Feb 2021

TCT 2021: oxygen sensing, pediatric CAR-T & the microbiome

Pavan Reddy • 24 Feb 2021